Seoul, South Korea

Chang-Won Cho

USPTO Granted Patents = 3 

Average Co-Inventor Count = 11.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chang-Won Cho: Innovator in Medical Treatments

Introduction

Chang-Won Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical treatments, particularly in the area of colitis disease. With a total of 3 patents, his work reflects a commitment to advancing healthcare solutions.

Latest Patents

One of his latest patents is a method for preventing or treating colitis disease, which involves administering a composition comprising K040706 as an active ingredient. This innovative approach aims to provide effective treatment for individuals suffering from colitis. Another notable patent involves a polysaccharide fraction derived from persimmon leaves, which exhibits immunostimulating and antitumor activation properties. This polysaccharide fraction consists of 60-80 wt % of neutral sugar, 18-39 wt % of uronic acid, and 0.5-10 wt % of 3-deoxy-D-manno-2-octulosonic acid (KDO) analogs.

Career Highlights

Chang-Won Cho has worked with esteemed organizations such as the Korea Food Research Institute and the Kyonggi University Industry & Academy Cooperation Foundation. His experience in these institutions has allowed him to collaborate on various research projects aimed at improving health outcomes.

Collaborations

Throughout his career, Chang-Won Cho has collaborated with notable colleagues, including Hee-Do Hong and Young-Chul Lee. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Chang-Won Cho's contributions to medical innovation, particularly in the treatment of colitis disease, highlight his role as a significant inventor in the field. His patents and collaborations reflect a dedication to improving healthcare solutions for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…